Carpal Tunnel Syndrome Release Using PSU Retractor
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01017471|
Recruitment Status : Unknown
Verified May 2012 by Boonsin Tangtrakulwanich, Prince of Songkla University.
Recruitment status was: Enrolling by invitation
First Posted : November 20, 2009
Last Update Posted : May 15, 2012
The investigators study aims to evaluate both efficacy and safety of carpal tunnel release using limited incision with the PSU retractor compared to standard incision.
The investigators will do a randomized controlled trial in 60 patients with carpal tunnel release and evaluate for outcome regarding pain, VAS score, return to work time, CTS score and complications at 6 months.
|Condition or disease||Intervention/treatment||Phase|
|Carpal Tunnel Syndrome||Procedure: Limited incision using PSU retractor||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Comparison Results of Carpal Tunnel Release Between Standard Incision and Limited Incision Using PSU Retractor: A Randomized Controlled Trial|
|Study Start Date :||September 2009|
|Estimated Primary Completion Date :||September 2012|
|Estimated Study Completion Date :||December 2012|
carpal tunnel release using standard incision
Procedure: Limited incision using PSU retractor
carpal tunnel release using limited incision with PSU retractor will be done by orthopaedic hand surgeons
- CTS score [ Time Frame: 1 year ]
- VAS score [ Time Frame: 1 year ]
- return to work time [ Time Frame: 1 year ]
- satisfaction score [ Time Frame: 1 year ]
- complication rate [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01017471
|Prince of Songkla University|
|Hatyai, Songkhla, Thailand, 90110|
|Principal Investigator:||Sunthorn Wongsiri, MD||Prince of Songkla University, Hatyai, Songkhla, Thailand|